Hot Pursuit     09-Feb-21
AstraZeneca Pharma tumbles after Q3 PAT declines 21% YoY
AstraZeneca Pharma India lost 4.24% to Rs 3734.05 after the company's net profit declined 21.2% to Rs 21.05 crore in Q3 FY21 from Rs 26.7 crore in Q3 FY20.
Net sales for Q3 FY21 stood at Rs 200.25 crore, a 10.5% fall over Rs 223.86 crore recorded in Q3 FY20. The result was announced after market hours yesterday, 8 February 2021.

Profit before tax fell 19.6% to Rs 28.30 crore in Q3 FY21 over Q3 FY20. Tax expense fell 12.1% to Rs 7.74 crore in Q3 FY21 over Q3 FY20.

AstraZeneca Pharma India is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease.

Previous News
  Astrazeneca Pharma India standalone net profit rises 184.76% in the March 2021 quarter
 ( Results - Announcements 25-May-21   17:28 )
  AstraZeneca Pharma India hits 52-week low
 ( Hot Pursuit - 18-Feb-22   14:51 )
  Astrazeneca Pharma India standalone net profit declines 54.63% in the September 2021 quarter
 ( Results - Announcements 10-Nov-21   08:11 )
  Astrazeneca Pharma India to table results
 ( Corporate News - 31-Oct-23   14:03 )
  Astrazeneca Pharma India standalone net profit rises 204.97% in the March 2019 quarter
 ( Results - Announcements 25-May-19   15:13 )
  AstraZeneca Pharma receives DCGI approves to import pharmaceutical formulation for Dapagliflozin Tablets
 ( Corporate News - 24-Jul-23   18:05 )
  AstraZeneca Pharma hits 52 week high after Q1 PAT soars to Rs 54 cr
 ( Hot Pursuit - 14-Aug-23   16:04 )
  Astrazeneca Pharma India to convene board meeting
 ( Corporate News - 29-Oct-19   16:53 )
  Astrazeneca Pharma India standalone net profit rises 2.57% in the March 2022 quarter
 ( Results - Announcements 27-May-22   08:06 )
  Astrazeneca Pharma India to launch Osimertinib Tablets (Tagrisso™)
 ( Corporate News - 22-Jul-17   10:02 )
  Astrazeneca Pharma India reports standalone net loss of Rs 27.96 crore in the September 2014 quarter
 ( Results - Announcements 04-Nov-14   08:42 )
Other Stories
  PEL board OKs ad hoc appointments post Rupen Patel's passing
  06-Jul-24   16:41
  Info Edge Q1 FY25 billings climb 11% YoY
  06-Jul-24   15:50
  IndusInd Bank advances climb 16% YoY in Q1 FY25
  06-Jul-24   15:18
  Adani Wilmar reports 13% volume growth in Q1 FY25
  06-Jul-24   14:44
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
Back Top